CHGCY (Chugai Pharmaceutical Co) Median PS Value : $12.95 (As of Dec. 11, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Chugai Pharmaceutical Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Chugai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $2.326. Chugai Pharmaceutical Co's 10-Year median PS Ratio is 5.5675. Therefore, the Median PS Value for today is $12.95.

As of today (2024-12-11), Chugai Pharmaceutical Co's share price is $22.22. Chugai Pharmaceutical Co's Median PS Value is $12.95. Therefore, Chugai Pharmaceutical Co's Price to Median PS Value for today is 1.72.

The historical rank and industry rank for Chugai Pharmaceutical Co's Median PS Value or its related term are showing as below:

CHGCY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.85 Med: 1.66 Max: 3.23
Current: 1.72

During the past 13 years, the highest Price to Median PS Value of Chugai Pharmaceutical Co was 3.23. The lowest was 0.85. And the median was 1.66.

CHGCY's Price-to-Median-PS-Value is ranked worse than
84.51% of 523 companies
in the Drug Manufacturers industry
Industry Median: 0.91 vs CHGCY: 1.72

Chugai Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Chugai Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Median PS Value Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Get a 7-Day Free Trial

7.29

9.70

12.46

14.83

13.29

Chugai Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Median PS Value	Get a 7-Day Free Trial															14.05	13.29	11.96	12.06	-

Competitive Comparison of Chugai Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Price-to-Median-PS-Value falls into.

Chugai Pharmaceutical Co Median PS Value Calculation

Chugai Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	2.326	*	5.5675
	=	12.95

10-Year Median PS Ratio is 5.5675.
Chugai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.326.

Chugai Pharmaceutical Co (OTCPK:CHGCY) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Chugai Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	22.22	/	12.95
	=	1.72

Chugai Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

CHGCF:USA 4519:Japan CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.